Is Tenet Healthcare Corporation (THC) overvalued? · P/E 9.3, rev $20.66B
Tenet Healthcare Corporation (THC) is a medical care facilities company listed on NYSE.
This page asks whether Tenet Healthcare Corporation (THC) looks expensive on cached numbers — not a short thesis.
Latest reported THC revenue for 2024-12-31 was $20.66B. Net income was $4.06B. Revenue was up 0.6% from 2023-12-31 to 2024-12-31. THC currently screens at market cap $15.38B and trailing P/E 9.3.
THC currently screens at market cap $15.38B and trailing P/E 9.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next THC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the THC stock page for the full model, not this heading.
Not investment advice.